Domestic drug companies to activate development of bio-engineering products
Published: 2002-01-21 07:00:00
Updated: 2002-01-21 07:00:00
To pave an advanced way for the forthcoming bio-tech era the domestic leading pharmaceutical companies are actively taking part in the R&D investment for the development of bio-engineering products in view of keeping the future competitiveness over the world.
Dong-A who earlier opened wide ey...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
